Abaxis, Inc. (ABAX) to Report First Quarter Fiscal Year 2014 Financial Results Thursday, July 25, 2013
7/16/2013 11:12:38 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
UNION CITY, Calif., July 16, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the first quarter fiscal year 2014, ended June 30, 2013. The call will be at 4:15 p.m. ET on Thursday, July 25, 2013. The Company will report financial results for the first quarter fiscal year 2014 after the market closes on Thursday, July 25, 2013.
Participants can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or can listen via a live Internet web cast, which is available in the Investor Relations section of the Company's website at www.abaxis.com. A replay of the call is available by visiting www.abaxis.com for the next 30 days or by calling (877) 344-7529 or (412) 317-0088, confirmation code 10031352, through August 1, 2013.
Abaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia and Lyme disease. Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.
Lytham Partners, LLC
Chief Executive Officer
Joe Dorame, Joe Diaz & Robert Blum
SOURCE Abaxis, Inc.
Help employers find you! Check out all the jobs and post your resume.